Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Meihua International Medical Technologies Co., Ltd. (MHUA) Stock Forecast & Price Prediction China | NASDAQ | Healthcare | Medical Instruments & Supplies
$7.61
-6.41 (-45.72%)Did MHUA Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Meihua International is one of their latest high-conviction picks.
MHUA has shown a year-to-date change of -77.9% and a 1-year change of -85.0%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MHUA. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MHUA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to Meihua International based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Meihua International Medical Technologies Co., Ltd. has a market capitalization of $425.43M with a P/E ratio of 0.5x. The company generates $89.55M in trailing twelve-month revenue with a 10.4% profit margin.
Revenue growth is -16.2% quarter-over-quarter, while maintaining an operating margin of +8.5% and return on equity of +5.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Manufactures and distributes medical devices globally.
Meihua International Medical Technologies generates revenue through the design, manufacturing, and distribution of essential medical devices, such as syringes and infusion sets, serving a wide range of healthcare applications. The company targets hospitals, clinics, and healthcare providers, ensuring high-quality products through advanced technology and stringent quality control practices.
With a strong emphasis on innovation and a reliable distribution network, Meihua International is well-positioned to meet the increasing demand for quality healthcare solutions, making it a significant player in the healthcare and medical industries.
Healthcare
Medical Instruments & Supplies
619
Ms. Lee Leyi
China
2022
Meihua International Medical Technologies (Nasdaq: MHUA) announced it has been notified of its delisting from Nasdaq due to non-compliance with Listing Rule 5550(a)(2).
Meihua's delisting from Nasdaq signals financial instability and loss of investor confidence, potentially leading to decreased stock value and liquidity for shareholders.
Meihua International Medical Technologies will implement a 1-for-100 reverse share split and a dual-class share structure, effective November 24, 2025.
Meihua's reverse share split and dual-class structure may impact stock liquidity and voting power, potentially affecting investor sentiment and share price stability.
Meihua International Medical Technologies Co., Ltd. (Nasdaq: MHUA) reported its fiscal year 2024 financial results on April 25, 2025. The company manufactures disposable medical devices in China.
Meihua's financial results can impact stock performance, reflecting demand for medical devices, profitability, and growth potential in the healthcare sector.
Meihua International Medical Technologies (Nasdaq: MHUA) has regained compliance with Nasdaq's minimum bid price requirement, as confirmed by a notification received on October 3, 2024.
Meihua International's compliance with Nasdaq's minimum bid price requirement boosts investor confidence, signaling financial stability and reducing delisting risks.
Meihua International Medical Technologies Co., Ltd. announced news from Yangzhou, China, on September 20, 2024. Further details were not provided in the excerpt.
Meihua International Medical Technologies' developments may influence stock performance, market perception, and investment opportunities in the medical technology sector.
Meihua International Medical Technologies (Nasdaq: MHUA) will have CEO Xin Wang present recent corporate developments at a live event.
Meihua's CEO presentation may signal strategic updates and future growth prospects, impacting investor sentiment and stock performance in the medical device sector.
Analyst forecasts for Meihua International Medical Technologies Co., Ltd. (MHUA) are not currently available. The stock is trading at $7.61.
Analyst ratings for MHUA are not currently available. The stock is currently trading at $7.61. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MHUA are not currently available. The stock is trading at $7.61.
Meihua International Medical Technologies generates revenue through the design, manufacturing, and distribution of essential medical devices, such as syringes and infusion sets, serving a wide range of healthcare applications. The company targets hospitals, clinics, and healthcare providers, ensuring high-quality products through advanced technology and stringent quality control practices.
Price targets from Wall Street analysts for MHUA are not currently available. The stock is trading at $7.61.
Price targets from Wall Street analysts for MHUA are not currently available. The stock is trading at $7.61.
Analyst ratings for MHUA are not currently available. The stock is trading at $7.61.
Stock price projections, including those for Meihua International Medical Technologies Co., Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.